HighTower Advisors
CL icon

HighTower Advisors’s Colgate-Palmolive CL Stock Holding History

HighTower Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,700
Closed -$1K – 2250
2019
Q4 		$1K Buy
+1,700
New +$116K ﹤0.01% 2261

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

HighTower Advisors's CL Position: Q2 2026 in Review

HighTower Advisors reduced its Colgate-Palmolive (CL) stake by 32% in Q2 2026, selling an estimated $24.3M and leaving 579,234 shares worth $53.1M. The position accounts for 0.05% of the portfolio, ranked #364.

HighTower Advisors first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $101M in Q3 2024. 2,032 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • HighTower Advisors held 579,234 shares of Colgate-Palmolive worth $53.1M as of Q2 2026.
  • HighTower Advisors sold 278,102 Colgate-Palmolive shares in Q2 2026, an estimated $24.3M.
  • Colgate-Palmolive made up 0.05% of HighTower Advisors's portfolio in Q2 2026, its #364 holding.
  • HighTower Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • HighTower Advisors's Colgate-Palmolive position peaked at $101M in Q3 2024.
  • 2,032 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.